Join
Live feed
·
INSIDERFilingvia Quantisnow
Avenue Therapeutics Inc. logo

Director Herskowitz Neil sold $46 worth of shares (23 units at $2.00), decreasing direct ownership by 19% to 97 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATXI· Avenue Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXI (Avenue Therapeutics Inc.) and more on Quantisnow.